Skip to content
Home/Companies/Biotech/Deka Biosciences

Deka Biosciences

Biotech·United States·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Deka Biosciences?

Deka Biosciences is an American Biotech company, currently owned by Leaps by Bayer since 2021.

Hand-verified · updated 2026-07-16

Open JSON · CC-BY
Leaps by Bayer
Investor
Leaps by Bayer
Leaps by Bayer · 2015 · Evergreen

Key facts

HQUnited States
SectorBiotech
StatusActive

More from Leaps by Bayer

Other portfolio companies in the same fund.

Celea Therapeutics
Celea Therapeutics
Active
BiotechUS· 2026
Leaf Agriculture
Active
ClimateTechUS· 2026
Sabanto
Active
AgTechUS· 2026
SonoThera
SonoThera
Active
BiotechUS· 2026
Souffle Therapeutics
Active
BiotechUS· 2025
WellTheory
WellTheory
Active
HealthTechUS· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Deka Biosciences?

Deka Biosciences is currently owned by Leaps by Bayer, through Leaps by Bayer, since 2021.

When did Leaps by Bayer acquire Deka Biosciences?

Leaps by Bayer acquired Deka Biosciences in 2021.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue